Dr. Libao Xie earned his Ph.D. in Preventive Veterinary Medicine from the Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences. His research interests include viral vector development, and gene therapy.He has extensive experience in molecular biology, virology, and genetic modification techniques, including viral construct design, CRISPR-Cas9 genome editing, and in vivo disease model development. Dr. Xie led a funded project on AAV-mediated gene therapy in humanized mouse models and has participated in multiple national and institutional research initiatives related to virus tropism. His work has resulted in several peer-reviewed publications and multiple patent applications.
Xie, L., Fan, N., Ding, X., Zhang, T., Wang, W., Ji, P., & Wu, H. (2025). Comparative transcriptomic and metabolomic analysis of FTO knockout and wild-type porcine iliac artery endothelial cells. Gene, 936, 149094.
Xie, L., Han, Y., Ma, Y., Yuan, M., Li, W., Li, L. F., ... & Qiu, H. J. (2020). P108 and T109 on E2 glycoprotein domain I are critical for the adaptation of classical swine fever virus to rabbits but not for virulence in pigs. Journal of Virology, 94(17), 10-1128.
Li, Y., Xie, L., Zhang, L., Wang, X., Li, C., Han, Y., ... & Qiu, H. J. (2018). The E2 glycoprotein is necessary but not sufficient for the adaptation of classical swine fever virus lapinized vaccine C-strain to the rabbit. Virology, 519, 197-206.
